| Pharmaceutical Information |
| Drug Name |
Ioflupane i-123 |
| Drug ID |
BADD_D01179 |
| Description |
Ioflupane (I-123) is a radiopharmaceutical used to image dopamine neurons and diagnose Parkinsonian syndromes. |
| Indications and Usage |
Ioflupane I-123 is a SPECT (single photon emission computerized tomography) agent used to distinguish between Parkinson’s syndrome tremors and essential tremor. |
| Marketing Status |
approved |
| ATC Code |
Not Available |
| DrugBank ID |
DB08824
|
| KEGG ID |
Not Available
|
| MeSH ID |
C087552
|
| PubChem ID |
3086674
|
| TTD Drug ID |
D02GJZ
|
| NDC Product Code |
17156-210; 69945-166 |
| UNII |
3MM99T8R5Q
|
| Synonyms |
2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane | beta-CIT-FP | N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iodophenyl)tropane | FP-CIT | FPCIT | (O-methyl-11C)beta-CIT-FP | fluoropropylcarbomethoxyiodophenylnortropane | I(123)-N-omega-fluoropropyl-2-beta-carbomethoxy-3-beta(4-iodophenyl)nortropane | I(123)-N-fluoropropyl-2-beta-carbomethoxy-3-(4-iodophenyl)nortropane | (18F)FP-CIT | 123I-FP-CIT |
|
| Chemical Information |
| Molecular Formula |
C18H23FINO2 |
| CAS Registry Number |
155798-07-5 |
| SMILES |
COC(=O)C1C2CCC(N2CCCF)CC1C3=CC=C(C=C3)I |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
